Chlorpromazine for psychosis induced aggression or agitation.
BACKGROUND
Agitated or violent behaviour constitutes 10% of all emergency psychiatric treatment. Some guidelines do not recommend the use of chlorpromazine for rapid tranquillisation but it is still often used for this purpose.


OBJECTIVE
To examine the effects of oral or intramuscular chlorpromazine for psychosis induced agitation or aggression.


METHODS
We searched the Cochrane Schizophrenia Group Trials Register (up to July 2009) which is based on regular searches of CINAHL, EMBASE, MEDLINE and PsycINFO.


METHODS
Randomised control trials or double blind trials (implying randomisation) comparing chlorpromazine with another drug or placebo for people who are thought to be acutely aggressive or agitated due to psychotic illness.


METHODS
We extracted data independently. For dichotomous data we calculated relative risks (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis based on a fixed-effects model.


RESULTS
One study (total n=30) met the inclusion criteria. When compared with haloperidol (Man 1973) (1 RCT, n=30) people allocated chlorpromazine were no more likely to have one additional injection than those allocated haloperidol (RR 3.00 CI 0.13 to 68.26). This remained true for 2-4 injections (RR 0.90 CI 0.52 to 1.55) and for 5 or more injections (RR 0.75 CI 0.20 to 2.79). Two people allocated chlorpromazine had sudden, serious hypotension while no one allocated haloperidol had such an effect (RR 5.00 CI 0.26 to 96.13). No extrapyramidal symptoms were observed. One person allocated chlorpromazine developed status epilepticus (RR 3.00 CI 0.13 to 68.26).


CONCLUSIONS
Overall the quality of evidence is limited, poor and dated. Where drugs that have been better evaluated are available, it may be best to avoid use of chlorpromazine. Where chlorpromazine is used for acute aggression or where choices are limited, relevant trials are possible and urgently needed.
Ahmed
Uzair
U
Parkside Lodge, Leeds PFT, Leeds, UK, LS12 2AE.
Jones
Hannah
H
Adams
Clive E
CE
D000284:Administration, Oral; D000374:Aggression / Q000187:drug effects* / Q000523:psychology; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D002746:Chlorpromazine / Q000008:administration & dosage*; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D007273:Injections, Intramuscular; D011595:Psychomotor Agitation / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology
D014150:Antipsychotic Agents; D006220:Haloperidol; D002746:Chlorpromazine
Stat Med. 2002 Jun 15;21(11):1539-58
12111919
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD005146
19588366
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004278
18254045
BMJ. 1997 Sep 6;315(7108):600
9302962
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003729
15846678
BMJ. 2007 Oct 27;335(7625):865
17954514
J Gen Intern Med. 1992 Nov-Dec;7(6):623-9
1453246
Psychol Med. 1972 Nov;2(4):422-5
4656537
Hosp Community Psychiatry. 1990 Jul;41(7):761-70
2142118
Psychiatr Q. 1964 Jan;38:42-63
14148394
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002084
16855984
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006391
17253592
J Clin Exp Psychopathol Q Rev Psychiatry Neurol. 1961 Jul-Sep;22:151-62
14498342
Stat Med. 2002 Oct 15;21(19):2971-80
12325113
Acta Psychiatr Scand. 2000 Feb;101(2):87-103
10706008
Br J Psychiatry. 2004 Jul;185:63-9
15231557
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001943
17943763
Am J Psychiatry. 1960 May;116:973-80
13791594
Curr Ther Res Clin Exp. 1967 Aug;9(8):434-6
4962467
Health Technol Assess. 1999;3(5):iii-92
10982317
Lancet. 2001 Apr 14;357(9263):1191-4
11323066
Am J Psychiatry. 1982 Feb;139(2):212-5
7055293
Int J Epidemiol. 2002 Feb;31(1):140-9
11914310
BMJ. 1997 Sep 13;315(7109):629-34
9310563
Psychopharmacologia. 1965 Feb 15;7(2):89-106
5318926
Cochrane Database Syst Rev. 2004;(3):CD000525
15266432
BMJ. 2007 Jan 6;334 Suppl 1:s7
17204765
BMJ. 1996 Nov 9;313(7066):1200
8916759
BMJ. 2003 Sep 27;327(7417):708-13
14512476
Psychosomatics. 1973 Jan-Feb;14(1):59-63
4605009
Br J Psychiatry. 2000 Mar;176:249-52
10755072
Curr Ther Res Clin Exp. 1969 Dec;11(12):784-92
4984044
S Afr Med J. 1971 Aug 28;45(34):945-7
4939661
Am J Epidemiol. 1999 May 1;149(9):876-83
10221325
Cochrane Database Syst Rev. 2000;(2):CD001163
10796606
Synapse. 1987;1(2):133-52
2905529
Am J Psychiatry. 1964 Dec;121:597-600
14239465
J Nerv Ment Dis. 1988 Sep;176(9):558-61
3418329
Ann Clin Psychiatry. 2005 Jul-Sep;17(3):113-35
16433053
BMJ. 2007 Oct 27;335(7625):869
17954515